Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7914066 | 8244498 | I | 7914066-5 | 20111110 | 20111115 | EXP | US-ASTELLAS-2011US007447 | ASTELLAS | YR | F | Y | 20111114 | OT | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7914066 | 1018046025 | PS | ERLOTINIB HYDROCHLORIDE | 1 | ORAL | 150 MG, UID/QD | 021743 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7914066 | 1018046025 | LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7914066 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 7914066 | DEATH |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7914066 | 1018046025 | 20110920 | 20111110 | 52 | DAY |